Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial - Concepedia

Concepedia

Publication | Closed Access

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

214

Citations

48

References

2021

Year

Ana Cristina de Medeiros Ribeiro, Nádia Emi Aikawa, Carla Gonçalves Schahin Saad, Emily Figueiredo Neves Yuki, Tatiana do Nascimento Pedrosa, Solange Fusco, Priscila Tagliaferro Rojo, Rosa Maria Rodrigues Pereira, Samuel Katsuyuki Shinjo, Danieli Andrade,

Nature Medicine

VaccinationRheumatologyVaccine SafetyAutoimmune Rheumatic DiseasesAutoimmune DiseaseVaccine DevelopmentPhase 4Rheumatic DiseasesImmunologyVaccine EfficacyMedicineVaccine ResearchRheumatoid Arthritis

References

	Year	Citations

Page 1

Page 1